Alliancebernstein L.P. Teva Pharmaceutical Industries LTD Transaction History

Alliancebernstein L.P.

  • $278 Billion
  • Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Alliancebernstein L.P. holds 218,535 shares of TEVA stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
218,535
Previous 215,734 1.3%
Holding current value
$3.82 Million
Previous $3.04 Million 16.66%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $35,796 - $48,737
2,801 Added 1.3%
218,535 $3.55 Million
Q1 2024

May 14, 2024
SELL
$10.67 - $14.43 $27,368 - $37,012
-2,565 Reduced 1.17%
215,734 $3.04 Million
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $73,835 - $96,658
-9,093 Reduced 4.0%
218,299 $2.28 Million
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $61,597 - $88,114
-8,235 Reduced 3.49%
227,392 $2.32 Million
Q2 2023

Aug 15, 2023
SELL
$7.2 - $9.47 $15,969 - $21,004
-2,218 Reduced 0.93%
235,627 $1.77 Million
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $85,907 - $116,838
-10,276 Reduced 4.14%
237,845 $2.1 Million
Q4 2022

Feb 14, 2023
SELL
$7.95 - $9.48 $107,404 - $128,074
-13,510 Reduced 5.16%
248,121 $2.26 Million
Q3 2022

Nov 15, 2022
BUY
$6.86 - $11.95 $27,892 - $48,588
4,066 Added 1.58%
261,631 $2.11 Million
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $7,306 - $10,296
990 Added 0.39%
257,565 $1.94 Million
Q1 2022

May 13, 2022
SELL
$7.33 - $9.39 $3.03 Million - $3.88 Million
-413,407 Reduced 61.7%
256,575 $2.41 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $3.06 Million - $3.95 Million
387,389 Added 137.08%
669,982 $5.37 Million
Q3 2021

Nov 10, 2021
SELL
$8.38 - $10.18 $5,958 - $7,237
-711 Reduced 0.25%
282,593 $2.75 Million
Q2 2021

Jul 30, 2021
SELL
$9.9 - $11.56 $73,378 - $85,682
-7,412 Reduced 2.55%
283,304 $2.81 Million
Q1 2021

May 06, 2021
SELL
$10.34 - $12.81 $87,497 - $108,398
-8,462 Reduced 2.83%
290,716 $3.36 Million
Q4 2020

Feb 08, 2021
SELL
$8.61 - $11.04 $261,167 - $334,876
-30,333 Reduced 9.21%
299,178 $2.89 Million
Q3 2020

Nov 12, 2020
BUY
$8.57 - $12.69 $50,588 - $74,909
5,903 Added 1.82%
329,511 $2.97 Million
Q2 2020

Aug 13, 2020
SELL
$8.12 - $13.12 $395,151 - $638,471
-48,664 Reduced 13.07%
323,608 $3.99 Million
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $222,977 - $448,288
33,330 Added 9.83%
372,272 $3.34 Million
Q4 2019

Feb 18, 2020
SELL
$6.53 - $10.72 $6,575 - $10,795
-1,007 Reduced 0.3%
338,942 $3.32 Million
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $41.2 Million - $64.2 Million
-6,686,351 Reduced 95.16%
339,949 $2.34 Million
Q2 2019

Aug 14, 2019
SELL
$8.12 - $15.72 $47.7 Million - $92.4 Million
-5,878,746 Reduced 45.55%
7,026,300 $64.9 Million
Q1 2019

May 14, 2019
BUY
$15.58 - $20.01 $56.7 Million - $72.8 Million
3,638,152 Added 39.26%
12,905,046 $202 Million
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $2.74 Million - $4.48 Million
-187,945 Reduced 1.99%
9,266,894 $143 Million
Q3 2018

Nov 08, 2018
BUY
$21.06 - $25.65 $48.3 Million - $58.8 Million
2,291,171 Added 31.98%
9,454,839 $204 Million
Q2 2018

Aug 13, 2018
SELL
$16.77 - $24.71 $3.17 Million - $4.67 Million
-188,839 Reduced 2.57%
7,163,668 $174 Million
Q1 2018

May 14, 2018
SELL
$16.68 - $22.07 $2.4 Million - $3.17 Million
-143,652 Reduced 1.92%
7,352,507 $126 Million
Q4 2017

Feb 13, 2018
SELL
$11.23 - $19.1 $56.8 Million - $96.6 Million
-5,058,097 Reduced 40.29%
7,496,159 $142 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $193 Million - $404 Million
12,554,256
12,554,256 $221 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email